I. RATIONAL APPROACHES TO THE DEVELOPMENT OF ANTICANCER DRUGS. POSSIBLE IMPROVEMENTS OF CYTOTOXIC AGENTS.
D000818:Animals; D000970:Antineoplastic Agents; D002277:Carcinoma; D002279:Carcinoma 256, Walker; D002626:Chemistry, Pharmaceutical; D003603:Cytotoxins; D005947:Glucose; D006863:Hydrogen-Ion Concentration; D007773:Lactates; D009374:Neoplasms, Experimental; D009588:Nitrogen Mustard Compounds; D010084:Oxidation-Reduction; D010600:Pharmacology; D051381:Rats; D012106:Research
D000970:Antineoplastic Agents; D003603:Cytotoxins; D007773:Lactates; D009588:Nitrogen Mustard Compounds; D005947:Glucose
ANTINEOPLASTIC AGENTS; CARCINOMA 256, WALKER; CHEMISTRY, PHARMACEUTICAL; EXPERIMENTAL LAB STUDY; GLUCOSE; HYDROGEN-ION CONCENTRATION; LACTATES; NEOPLASMS, EXPERIMENTAL; NITROGEN MUSTARD COMPOUNDS; OXIDATION-REDUCTION; PHARMACOLOGY; RATS